BRPI0823200A2 - composicao farmaceutica antimicotica e prebiotica e um metodo para tratamento de vaginite por candida - Google Patents

composicao farmaceutica antimicotica e prebiotica e um metodo para tratamento de vaginite por candida

Info

Publication number
BRPI0823200A2
BRPI0823200A2 BRPI0823200A BRPI0823200A BRPI0823200A2 BR PI0823200 A2 BRPI0823200 A2 BR PI0823200A2 BR PI0823200 A BRPI0823200 A BR PI0823200A BR PI0823200 A BRPI0823200 A BR PI0823200A BR PI0823200 A2 BRPI0823200 A2 BR PI0823200A2
Authority
BR
Brazil
Prior art keywords
biotic
pharmaceutical composition
antimicrobial pharmaceutical
candida vaginitis
treating candida
Prior art date
Application number
BRPI0823200A
Other languages
English (en)
Inventor
Vladimirovich Dikovskiy Aleksander
Anatolievich Rudoi Boris
Valentinovich Dorozhko Oleg
Original Assignee
Vladimirovich Dikovskiy Aleksander
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vladimirovich Dikovskiy Aleksander filed Critical Vladimirovich Dikovskiy Aleksander
Publication of BRPI0823200A2 publication Critical patent/BRPI0823200A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0823200A 2008-09-30 2008-09-30 composicao farmaceutica antimicotica e prebiotica e um metodo para tratamento de vaginite por candida BRPI0823200A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU2008/000621 WO2010039054A1 (ru) 2008-09-30 2008-09-30 Фармацевтическая композиция антимикотиков и пребиотиков и способ лечения кандидозных вагинитов

Publications (1)

Publication Number Publication Date
BRPI0823200A2 true BRPI0823200A2 (pt) 2019-09-24

Family

ID=42073688

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0823200A BRPI0823200A2 (pt) 2008-09-30 2008-09-30 composicao farmaceutica antimicotica e prebiotica e um metodo para tratamento de vaginite por candida

Country Status (6)

Country Link
US (1) US8980303B2 (pt)
EP (1) EP2343088A4 (pt)
CN (1) CN102123736A (pt)
BR (1) BRPI0823200A2 (pt)
EA (1) EA024145B1 (pt)
WO (1) WO2010039054A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013113767A1 (en) 2012-01-31 2013-08-08 Bioclin Bv Method for administration of a probiotic
WO2014026707A1 (en) * 2012-08-13 2014-02-20 Edko Pazarlama Tanitim Ticaret Limited Sirketi Anti-vaginitis compositions with improved release and adherence
CN103690476A (zh) * 2014-01-06 2014-04-02 海南海力制药有限公司 微粉化硝酸芬替康唑制剂组合物及其制备方法
EP3117827B1 (en) * 2014-03-13 2021-11-03 Singapore Ze&Z International Pte. Ltd. Composition for vagina and use of the composition
CN104490763A (zh) * 2015-01-07 2015-04-08 河北仁合益康药业有限公司 一种那他霉素阴道栓剂组合物及其制备方法
CN114647779A (zh) * 2015-08-12 2022-06-21 爱康迪健康规划服务股份有限公司 信息处理装置、信息处理方法和记录介质
RU2709464C2 (ru) 2015-09-29 2019-12-18 Кимберли-Кларк Ворлдвайд, Инк. Синергическая композиция для сохранения здорового баланса микрофлоры
US12029748B2 (en) 2017-02-28 2024-07-09 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
JP7017322B2 (ja) * 2017-06-05 2022-02-08 雪印メグミルク株式会社 乳酸菌の生残性向上及び／又は増殖促進用組成物
CN108324932A (zh) * 2018-04-26 2018-07-27 霍尔果斯汉智医药科技有限公司 一种乳铁蛋白阴道膨胀栓及其制备方法
CN109464655B (zh) * 2019-01-08 2021-08-13 福建龙生生物科技有限公司 一种防治阴道炎的外用胶囊制剂
CN121668096B (zh) * 2026-02-10 2026-04-21 长沙融禧生物科技有限公司 一种用于调节阴道微生态平衡的抑菌促菌双相凝胶及制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1390803A (en) * 1972-07-18 1975-04-16 Wootton L W Medicinal tampons and compositions containing lactulose
US4983393A (en) * 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
ATE429212T1 (de) 1995-12-26 2009-05-15 Cns Inc Verabreichungssystem für inulindiätfasern
US6964949B2 (en) * 2000-05-24 2005-11-15 Shanghai Jiao Da Onlly Co., Ltd. Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in the vagina and the use thereof
DE102004037505A1 (de) 2004-08-03 2006-02-23 Henkel Kgaa Präbiotische Intimpflege
RU2354385C2 (ru) * 2007-02-14 2009-05-10 Александр Владимирович Диковский Фармкомпозиция для лечения кандидозных вульвовагинитов

Also Published As

Publication number Publication date
EP2343088A1 (en) 2011-07-13
EA201001536A1 (ru) 2011-08-30
US8980303B2 (en) 2015-03-17
US20110202025A1 (en) 2011-08-18
WO2010039054A1 (ru) 2010-04-08
EA024145B1 (ru) 2016-08-31
EP2343088A4 (en) 2012-04-11
CN102123736A (zh) 2011-07-13

Similar Documents

Publication Publication Date Title
BRPI1014277A2 (pt) método para melhorar o perfil de dissolução de um material biologicamente ativo
BRPI0917358A2 (pt) formulação farmacêutica de liberação controlada e método.
BRPI0907837A2 (pt) Dispositivos médicos para o tratamento de um local-alvo e método associado
BRPI0920206A2 (pt) dispositivos e métodos para manipulação de um eixo de cateter
BRPI0810525A2 (pt) Composições e métodos para a profilaxia e tratamento de dependência química
BRPI0915205A2 (pt) compostos e composições úteis para o tratamento de malária
BRPI0811589A2 (pt) Composição farmacêutica e método para tratar câncer
BRPI0715014A2 (pt) Método e dispositivo para o tratamento de recipientes
BRPI0813047A2 (pt) "método para tratar um substrato metálico e composição para tratar um substrato metálico"
BRPI0922475A2 (pt) composto, composição farmacêutica , método para tratar câncer, e, uso de um composto.
BRPI1006145A2 (pt) "composição e método para tratamento de diabetes".
BR112012028514A2 (pt) composição para o tratamento da água residual e processo para o tratamento de água residual
BRPI0913585A2 (pt) composto, método para fabricar um composto, composição farmacêutica, uso de um composto, e, método para o tratamento ou prevenção de distúrbios
BRPI0907977A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
BRPI0913129A2 (pt) método para tratamento de hiperuricemia empregando um inibidor de sglt2 e composição contendo o mesmo
BR112012001361A2 (pt) composição de aço para mancal, componente de mancal, mancal, e, método para formar um componente de mancal.
BRPI0909164A2 (pt) método e composições para o tratamento de câncer
BRPI0717322A2 (pt) Métodos e aparelho para codificação de primeira passagem eficiente um codificador de múltiplas passagens
BRPI0906244A2 (pt) Composto, composição farmacêutica, método para tratar um distúrbio cognitivo, psicótico, mediado por neurotransmissores ou um distúrbio neuronal em um indivíduo, uso de um composto e kit
BRPI1013163A2 (pt) método para o revestimento de um substrato, e substrato tendo um revestimento
BRPI0907974A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
EP2316267A4 (en) ANTIBACTERIAL ACTIVE SUBSTANCE AND DISINFECTING PROCEDURE
BRPI0909924A2 (pt) ferramenta e método para remoção de implante
BRPI0719707A2 (pt) Composição e método para dermatite causada por fraldas.
BRPI0909459A2 (pt) sistema e método para recompletação de um poço antigo

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.